Immunophenotyping by Flow Cytometry: Leukemia Diagnostic Panel (CLL/HCL/SLL Basic) in UAE | 1800 AED | DHA Accredited

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Leukemia Diagnostic Panel (CLL/HCL/SLL Basic) uses advanced multicolor flow cytometry to precisely identify the unique immunophenotypic signatures of chronic lymphocytic leukemia, hairy cell leukemia, and small lymphocytic lymphoma, enabling early, targeted treatment decisions. This gold‑standard method interrogates surface and intracellular markers from peripheral blood or bone marrow aspirate.

Feature	Our Test (Flow Cytometry Panel)	Closest Alternative (IHC / Single Marker)
Precision	99.9% sensitivity with full immunophenotypic profile	Limited to a few markers; risk of missing co-existing diseases
Methodology	Multicolor Flow Cytometry, ISO 9001:2015 certified	Immunohistochemistry or manual differential; lower resolution
Speed	Same‑day report if sample arrives by 9 AM	Often 2–5 working days
Logistics	Hospital extraction only – specimen collected by trained medical staff in a hospital setting	May require multiple hospital visits for additional tests

Physician Insight & Safety Protocols

“Flow cytometry provides a powerful cellular snapshot, but the full diagnostic picture requires integrating these results with your complete medical history and physical examination. As a specialist in diagnostic radiology, I emphasize that no single laboratory value defines a leukemia subtype—clinical correlation is the cornerstone of precise management.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011

Medication Advisory

Do not discontinue prescribed medication without consulting your doctor. Some therapies can alter immunophenotype expression; always provide a complete medication list before sample collection.

Exclusion Criteria and Red Flags

Exclusion Criteria: Hemodynamic instability, active severe infection that may alter blood cell populations, or recent cytotoxic therapy (within 2 weeks) unless specifically requested by your physician.
Red Flags (Seek Emergency Care): New onset high fever (>38.5°C), excessive bruising or bleeding, severe bone pain, or sudden neurological changes after sample collection.
Pre‑Test Mandatory: Complete clinical history (including medication list) must be provided. Sample must be shipped at controlled room temperature (18–22°C); DO NOT REFRIGERATE OR FREEZE. Contact us immediately if the cold‑chain is broken.

Patient FAQ & Clinical Guidance

1. What does the Leukemia Diagnostic Panel by Flow Cytometry detect?

Snippet Answer: The Leukemia Diagnostic Panel uses flow cytometry to identify specific cell markers, enabling accurate diagnosis of CLL, HCL, and SLL.

It analyzes surface and intracellular proteins on white blood cells from blood or bone marrow, classifying the disease subtype and guiding targeted therapy. This panel is the gold standard for distinguishing chronic lymphocytic leukemia from other indolent lymphomas.

2. How should I prepare for the blood or bone marrow sample collection?

Snippet Answer: No fasting is required, but inform your doctor of any medications and provide a complete clinical history to avoid interference.

Our hospital extraction team arranges a sterile, temperature‑controlled setup. You must report all current treatments, including supplements, as certain drugs can alter marker expression. Avoid any intramuscular injections on the day of sampling unless medically necessary.

3. How quickly will I receive my test results, and who will explain them?

Snippet Answer: Same-day results are available if the sample reaches the lab by 9 AM, and a specialist can guide you.

After the report is issued, you can schedule a telephonic post‑test consultation to discuss the findings with a DHA‑licensed specialist. All results are delivered through our secure patient portal and remain fully compliant with UAE health data privacy laws.

UAE Regulatory & Data Privacy Adherence

Data Privacy & Security: All patient data is processed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our facility is ISO 9001:2015 certified.

DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE

Clinical & Logistical Metadata

Test Name	Immunophenotyping by Flow Cytometry: Leukemia Diagnostic Panel (CLL/HCL/SLL Basic)
Price (AED)	1,800
Turnaround Time	Same-day if sample received by 9 AM; otherwise within 24 hours
Sample Type / Matrix	Peripheral blood or bone marrow aspirate
Methodology Used	Multicolor Flow Cytometry (ISO 9001:2015 certified)
ICD-10-CM Code	C91.1 (CLL), C91.4 (HCL), Z15.89 (genetic susceptibility)
LOINC Code	48767-8
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE